Aethlon Medical, Inc.
AEMD
$0.4253
-$0.0247-5.49%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -37.47% | 10.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -37.47% | 10.73% | |||
| Operating Income | 37.47% | -10.73% | |||
| Income Before Tax | 37.48% | -9.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 37.48% | -9.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 37.48% | -9.16% | |||
| EBIT | 37.47% | -10.73% | |||
| EBITDA | 38.54% | -11.11% | |||
| EPS Basic | 37.59% | 41.59% | |||
| Normalized Basic EPS | 37.57% | 41.58% | |||
| EPS Diluted | 37.59% | 41.59% | |||
| Normalized Diluted EPS | 37.57% | 41.58% | |||
| Average Basic Shares Outstanding | 0.18% | 86.88% | |||
| Average Diluted Shares Outstanding | 0.18% | 86.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
